The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 10, 2015
Filed:
Mar. 31, 2010
Applicants:
Hung-yun Lin, Schenectady, NY (US);
Faith B. Davis, West Sand Lake, NY (US);
Paul J. Davis, West Sand Lake, NY (US);
Shaker A. Mousa, Wynantskill, NY (US);
Inventors:
Hung-Yun Lin, Schenectady, NY (US);
Faith B. Davis, West Sand Lake, NY (US);
Paul J. Davis, West Sand Lake, NY (US);
Shaker A. Mousa, Wynantskill, NY (US);
Assignee:
NANOPHARMACEUTICALS LLC, Rensselaer, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 59/22 (2006.01); A61K 9/14 (2006.01); A61K 9/16 (2006.01); A61K 9/50 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); C07K 16/00 (2006.01); C12P 21/08 (2006.01); A61K 31/192 (2006.01); A61K 45/06 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
A61K 31/192 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/48853 (2013.01); A61K 47/48907 (2013.01); A61K 47/48915 (2013.01);
Abstract
Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.